Connect with us

Technology

Frost & Sullivan Released Report: “BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies”

Published

on

SHANGHAI, Sept. 2, 2024 /PRNewswire/ — Frost & Sullivan released a report, titled “BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies”. The report explores a global CDMO leading the “The Fourth Revolutionary Wave of Biologics Manufacturing” and pioneering the next generation of CDMO models.

The global biomanufacturing capacity gap and budget constraints have ignited the “The Fourth Revolutionary Wave of Biologics Manufacturing”, with production sites expanding towards million-liter scales. In this context, Contract Development and Manufacturing Organizations (CDMOs) have become key players in global biomanufacturing. In 2023, BiBo Pharma, founded in Boston, USA, introduced a new generation of ultra-large production platforms, marking a new era in biomanufacturing. BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies.

Part I: BiBo Pharma 1.0 : Reflecting on the Past – Originating in Boston, USA, and Navigating through the Global CDMO development Journey

In the increasingly competitive CDMO industry, BiBo Pharma continues to advance. This success is due not only to their precise grasp of market opportunities but also to their breakthroughs in core biopharmaceutical industrialization technologies. Sailing from Boston, BiBo Pharma has been committed to the commercial production of biologics since its inception. The company independently designed and manufactured the ultra-large stainless steel bioreactors and pioneers a new generation of production models. In 2023, BiBo Pharma successfully completed the construction of a 30,000L single-tank ultra-large-production line, and in March 2024, it successfully commenced operations.

BiBo Pharma developed a comprehensive technology platform for microbial fermentation, mammalian cell culture, gene therapy, and antibody-drug conjugates (ADC). This platform offers one-stop services from DNA to IND/BLA and large-scale commercial production. To date, BiBo Pharma has offered CDMO services for more than 130 large molecule projects. Their operations adhere to international quality and management standards, solidifying BiBo Pharma’s position on the global CDMO stage after a decade of dedicated effort, and pioneering the next generation of CDMO models.

Part II: BiBo Pharma 2.0: Current Focus – Upgrading Strategies and Expanding Capabilities

//30,000L Capacity Advantage and Global First Delivery Advantage as an Industry Pioneer//

Major global CDMOs are expanding their large-scale commercial production capacities by focusing on the construction of large-scale stainless steel bioreactors. The future direction involves advancing from the current 15,000L reactors to fourth-generation ultra-large-scale production technologies.

BiBo Pharma is the first and only CDMO to deliver a new generation of ultra-large stainless steel bioreactors with a maximum working volume of 30,000L per tank. This is an engineering scale-up of over 2.5 times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production. BiBo Pharma leverages economies of scale and cost-sharing to offer a potential solution to reduce costs on the basis of ensuring independently designed core equipment and a controllable supply chain.

PanFlex®-Engineering: Breaking Through the “Quality-Cost-Efficiency” Triangle  

The conventional factory construction process adopts an engineering design model that proceeds from the top level down to the lower levels. PanFlex®-Engineering employs a “Process is King” strategy, using standardized units to reverse-engineer a complete factory. As a result, PanFlex®-Engineering system transcends the impossible triangle of “quality-cost-efficiency.” Remarkably, it took less than 18 months to deliver a 30,000L ultra-large production platform, roughly half the time and cost of similar projects worldwide. In addition, the 30,000L platform passed quality audits from the U.S., EU, and Chinese clients. Leveraging its PanFlex®-Operation system, Bibo Pharma achieved a “Right on First Time” in March 2024 when the platform was put into operation with a 100% success rate in subsequent production.

Grand-CHO Platform: A “Three-in-one” Approach to Innovation

A “Three-in-One” approach to innovation——Grand-CHO Platform involves advances in cell line development, process research, and production technology for ultra-large-scale platforms.

Grand-CHO platform improves cell line expression and stability, optimizes commercial production processes of different scales, and offers other benefits. The second-generation Epic-CHO cell line achieves a high expression level of 10 g/L at the mini-pool stage and offers more than double the stability of leading international cell lines, laying a solid foundation for large-scale production.

Grand-CHO technology enables high-density and large-scale cell storage, while seamlessly integrating a 3,000L N-1 perfusion process and a 30,000L intensified Fed-batch production process. Compared to traditional methods, Grand-CHO technology reduces production cycle time by 30%, doubles the yield per fermentation volume, and cuts restart time for 30,000L projects from 60 days to 30 days. Grand-CHO technology, integrated with the 30,000L ultra-large-scale production line, is fundamentally transforming the overall production efficiency of biopharmaceuticals.  

Pulse Continuous Manufacturing (PCM)

The combination of BiBo Pharma’s PanFlex®-Engineering and Grand-CHO technology has led to a groundbreaking production model — Pulse Continuous Manufacturing (PCM). PCM releases a single high-volume batch upstream, such as 60,000 liters per pulse (60kL/P). It then processes multiple downstream batches continuously based on each unit’s operation time. PCM significantly improves production efficiency, boosting overall line efficiency by 50% to 300%. PCM’s success is driven by the interconnected equipment enabled by PanFlex®-Engineering. Additionally, BiBo’s P03 plant has implemented an automated process control system (PAS) that enables full digital integration across the facility, making the execution of the PCM model more efficient and seamless. 

Technology Integration Drives Reduction of Antibody Drug Production Cost to $10 per Gram

The primary initiative to solve the constraints of production costs, is the international breakthrough of the first-ever 30,000L single-tank ultra-large-scale production line. Integrating PanFlex®-Engineering, Grand-CHO technology, and a pulse continuous production mode, BiBo Pharma reduce antibody drug production cost from hundreds of dollars to $10 per gram.

An Engineering and Technical Service Provider

BiBo Pharma has launched the pioneering “Blue Whale Program,” a financial risk-free manufacturing solution powered by the PanFlex® system. This program offers tailored production line construction services to global clients, which reduces the construction costs and timelines by 50%. This allows clients to postpone capital expenditure decisions from Phase I/II to Phase III of clinical trials, giving them more time to make informed investment choices. Additionally, the program provides a risk reduction feature: fees paid by clients are refundable regardless of whether the product succeeds in the market. This effectively offers additional insurance for commercialization and mitigates risks in the R&D and production phases.

Part III: BiBo Pharma 3.0: Shaping the Future – Establishing Comprehensive Technology Industry Advantages and Leading the Next Chapter

BiBo Pharma establishes an intensive production model, which underpins the company a diversified, full-technology platform offering one-stop CDMO services. With its Boston R&D center and global production capabilities, BiBo Pharma delivers high-quality services adhering to international standards. BiBo Pharma utilizes its unparalleled industry advantages to empower the global biopharmaceutical companies by reshaping the cost structure of biologics.

Additionally, the “Blue Whale Program” expands BiBo Pharma’s established engineering solutions, reaching more clients with commercial production needs. Frost & Sullivan expects that these capabilities and advantages will position BiBo Pharma as the best solution for global pharmaceutical companies in the future.

To read the full content, go here: https://www.frost.com/news/press-releases/bibo-pharma-a-global-cdmo-leading-in-advanced-biopharmaceutical-manufacturing-technologies/

Media Contact
Contact: Qian Li
Company Name: Frost & Sullivan
Website: http://www.frostchina.com
Email: qian.li@frostchina.com 

View original content:https://www.prnewswire.com/apac/news-releases/frost–sullivan-released-report-bibo-pharma-a-global-cdmo-leading-in-advanced-biopharmaceutical-manufacturing-technologies-302235863.html

SOURCE Frost & Sullivan

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Mouser Electronics Explores How Artificial Intelligence Shapes Everyday Technologies and Experiences

Published

on

By

SHANGHAI, April 20, 2026 /PRNewswire/ — Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today announced the first 2026 installment of its Empowering Innovation Together (EIT) technology series, Engineering AI for Daily Life. This installment explores how artificial intelligence is increasingly embedded in everyday products and services, from assisted search and messaging tools to healthcare wearables that monitor personal well-being. As AI capabilities expand across consumer and connected devices, engineers continue to design systems that make these technologies more useful, intuitive, and trustworthy in real-world applications.

“AI is quickly moving from experimental technology into products people rely on every day, and engineers play a major role in shaping how it’s applied,” said Jeff Newell, President of Mouser Electronics. “As AI becomes embedded across consumer devices and connected systems, it’s important that these technologies are designed to support human expertise while remaining reliable and trustworthy. This EIT segment helps engineers explore the tools and insights they need to build the next generation of AI-enabled solutions.”

As AI agents and intelligent tools become integrated into homes, connected devices, and digital services, engineers are developing systems that enhance user judgment and keep users in control while maintaining transparency and privacy. New AI-powered platforms already demonstrate this potential – turning simple conversations into complete travel itineraries or providing deeper health insights through connected devices.

On The Tech Between Us podcast, Raymond Yin, Director of Technical Content at Mouser Electronics, and Dr. Marisa Tschopp, Senior Researcher at scip AG in Zurich, examine the new role of AI in human interaction and day-to-day experiences. They explore how AI advancements shape technology-enabled collaboration, including the long-term impact of daily integration and applications for mental health.

“AI is moving beyond experimental settings into the products people rely on every day,” said Yin. “Our first EIT navigates the next era in AI innovation, looking at how to use the technology to enhance people’s abilities and rethink how we can live for the better.”

In addition to the podcast, the EIT series includes an in-depth video, technical articles, a topic-related infographic, as well as subscriber-exclusive content, diving into everyday AI. By examining the range of cases where AI can level up technical expertise, engineers can build a class of tools to help reshape how people think, decide, and create while protecting privacy and control.

Established in 2015, Mouser’s Empowering Innovation Together program is one of the electronic component industry’s most recognized educational programs. To learn more, visit https://www.mouser.com/empowering-innovation/engineering-ai-daily/ and follow Mouser on Facebook, LinkedIn, X, and YouTube.

For more Mouser news and our latest new product introductions, visit https://www.mouser.com/newsroom/.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mouser-electronics-explores-how-artificial-intelligence-shapes-everyday-technologies-and-experiences-302745803.html

SOURCE Mouser Electronics

Continue Reading

Technology

The Global Economy Could Split in Very Different Directions by 2050

Published

on

By

Research from the BCG Henderson Institute Details Four Plausible Scenarios for the World over the Next 25 Years, Based on Analysis of More Than 100 Megatrends and a Century of Historical Data

BOSTON, April 20, 2026 /PRNewswire/ — The global economy could follow markedly different paths over the next 25 years. For business leaders, the challenge is how to make decisions today while preparing for a wide range of possible futures.

New Scenarios 2050 research from the BCG Henderson Institute (BHI), Boston Consulting Group’s think tank, anticipates four distinct futures that push boundaries but remain plausible. The report explores what each scenario could mean for businesses and how early signals may indicate which direction the world is heading.

Among the findings:

Global GDP growth could slow to about 1.8% or rise to 5.0% annually, with the economy reaching anywhere from 1.6 to 3.4 times today’s size.Global trade could fall to about 35% of GDP—roughly Cold War–era levels—or remain near current levels of about 60%.Defense spending could climb to as much as 7% of global GDP.Low-carbon electricity could account for 55% to 90% of power generation.

The report, Beyond Tomorrow: Four Scenarios for the World of 2050, is based on a century of historical data and analysis of more than 100 megatrends across technology, geopolitics, climate, society, and economics.

“The decisions made in the next 5 years will shape the next 25,” said Nikolaus Lang, global leader of the BCG Henderson Institute and a coauthor of the report. “Too often, the future is framed in extremes—either collapse or abundance. In reality, leaders need to be ready for a range of outcomes and make decisions that hold up across very different conditions.”

Four Plausible Futures Leaders Should Plan For

Each scenario presents a different operating environment for businesses, reflecting the range of conditions leaders may face.

Scenario 1: AI Abundance. Global cooperation on AI standards leads to faster productivity growth, wider access to technology, and abundant low-carbon energy:

Global GDP more than triples, growing by about 5% annually from 2025 to 2050—the highest level across BHI’s four plausible scenarios.Average working hours fall by about 25%, with four- or even three-day workweeks becoming common in some regions.AI-supported advances in new materials and carbon removal put the world on a delayed but credible path to net zero emissions.

Scenario 2: Battling Blocs. Geopolitical tensions divide the world into competing blocs, reducing cooperation and reshaping global trade:

Global trade falls to about 35% of global GDP, down from 57% in 2024—reversing decades of globalization.Defense spending rises to about 7% of global GDP, the highest across BHI’s four scenarios, as countries prioritize security and self-sufficiency.Global GDP growth slows to about 1.8% annually, the lowest across the four scenarios, underpinned by government spending on national security, pensions, and climate mitigation.

Scenario 3: Climate Coalition. A series of extreme weather events in the late 2020s push governments, industries, and consumers to prioritize climate resilience, accelerating the shift to low-carbon energy and infrastructure:

Global warming stabilizes at about 1.8°C.Carbon markets expand globally, with most major economies participating by 2040.The share of fossil fuels in the energy mix falls from 81% today to 35% in 2050, while electricity is generated almost entirely from low-carbon sources.Global GDP growth averages about 2.5% annually, reflecting a focus on the climate transition, slower population growth, and aging societies.

Scenario 4: Digital Darwinism. Rapid technological progress continues under limited regulation, driving strong growth while concentrating wealth and power among leading companies and tech-rich nations:

Global GDP grows at 4% per year, resulting in a near tripling of GDP.The richest 1% holds nearly half of global wealth, while the middle class continues to shrink.Gig-style and short-term contract work expands as AI and automation displace routine knowledge work.Defense spending rises to about 4% of GDP, up from 2.4% in 2024, as the global order becomes more fragmented. At the same time, global trade and supply chains remain open, driven by commercial interests.

What Leaders Can Do Now

 Across all four scenarios, the report highlights “low regret” moves that make sense for business leaders today, including:

Enhance structural resilience. Rebalance toward resilience over efficiency to maintain operations in a more volatile environment.Reimagine talent for aging populations and AI. Build strategies for intergenerational work, more flexible roles, and talent mobility—and recruit more widely, especially from emerging labor markets.Build digital flexibility and trust. Take a modular approach to tech and data stacks that accounts for rapidly changing technologies.Sharpen sensing and influencing capabilities. Develop sensing capacities along dimensions like regulation, geopolitics, resources, and technology. Build the capability to act on them quickly.Embrace a broader societal role. Prepare to shoulder more responsibility for workers’ well-being, local resilience, crisis management, and community needs.

“No one can predict exactly what 2050 will look like, but the forces shaping it are already visible,” said Alan Iny, a partner and director at BCG, a BCG Henderson Institute Fellow, and a coauthor of the report. “Planning for a single future is a gamble. The advantage will go to leaders who prepare for multiple futures and act to shape them before the direction of the world is clear.”

Download the publication here: https://www.bcg.com/publications/2026/beyond-tomorrow-four-scenarios-for-the-world-of-2050

Media Contact:                            
Eric Gregoire
+1 617 850 3783
gregoire.eric@bcg.com

About the BCG Henderson Institute
The BCG Henderson Institute is Boston Consulting Group’s strategy think tank, dedicated to exploring and developing valuable new insights from business, technology, and science by embracing the powerful technology of ideas. The Institute engages leaders in provocative discussion and experimentation to expand the boundaries of business theory and practice and to translate innovative ideas from within and beyond business. For more ideas and inspiration from the Institute, please visit our website and follow us on LinkedIn and X (formerly Twitter).

About Boston Consulting Group
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.

Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-global-economy-could-split-in-very-different-directions-by-2050-302746672.html

SOURCE Boston Consulting Group (BCG)

Continue Reading

Technology

DEKRA Korea to Acquire Global Product Service, Strengthening Consumer Electronics Testing and Certification Capabilities in Korea

Published

on

By

GIMHAE-SI, South Korea, April 20, 2026 /PRNewswire/ — DEKRA, a leading global provider of testing, inspection, and certification services, today announced it has signed a definitive agreement to acquire Global Product Service Co., Ltd (GPS), a prominent South Korean company renowned for its expertise in consumer electronics product testing and certification.

This strategic acquisition will significantly enhance DEKRA Korea’s capabilities within the rapidly growing consumer electronics sector, bringing together DEKRA’s global network and comprehensive service portfolio with GPS’s deep-rooted local knowledge and decades of experience serving South Korea’s leading manufacturers.

GPS has established a strong reputation for its in-depth technical expertise and unwavering commitment to quality, particularly within the consumer electronics market. For many years, GPS has been a trusted partner to major South Korean electronics companies, providing testing and certification services that ensure product safety, performance, and compliance with international standards.

The successful acquisition is a result of the strong collaboration and commitment from both DEKRA and GPS. Key representatives who participated in the signing, embodying this collaboration, were Dr. Kilian Aviles, Executive Vice President of DEKRA Group and Head of Asia Pacific Region; Ming Sheng, Vice President of Automotive Testing, DEKRA China; Young Seok Lee, CEO of Global Product Service Co., Ltd; and Seong Su Kim, Director of Global Product Service Co., Ltd.

“We are thrilled to welcome Global Product Service Co., Ltd to the DEKRA family,” said Dr. Kilian Aviles, Executive Vice President of DEKRA Group and Head of Asia Pacific Region. “This acquisition represents a significant milestone in our growth strategy in South Korea. GPS’s deep understanding of the local market, combined with their specialized expertise in consumer electronics, perfectly complements DEKRA’s global strengths. Together, we will offer unparalleled testing and certification solutions to our clients, empowering them to bring innovative and reliable products to market with greater speed and confidence.”

The integration of GPS into DEKRA Korea will leverage synergies in technology, talent, and market reach. This will enable DEKRA to further support South Korean manufacturers as they navigate complex global regulatory landscapes and strive for excellence in product development and quality assurance. Clients can expect a seamless transition and continued access to the high-quality services they have come to rely on from both organizations.

Young Seok Lee, CEO of Global Product Service Co., Ltd commented, “Joining forces with DEKRA is an exciting opportunity for GPS. DEKRA’s global reach and extensive resources will allow us to expand our service offerings and better serve our existing and future clients. We are confident that this partnership will create significant value for the South Korean consumer electronics industry, providing enhanced support and innovation.”

About DEKRA

For more than 100 years, DEKRA has been a trusted name in safety. Founded in 1925 with the original goal of improving road safety through vehicle inspections, DEKRA has grown to become the world’s largest independent, non-listed expert organization in the field of testing, inspection, and certification. Today, as a global partner, the company supports its customers with comprehensive services and solutions to drive safety and sustainability forward—fully aligned with DEKRA’s anniversary motto, “Securing the Future.” In 2024, DEKRA generated revenue of 4.3 billion euros. Around 48,000 employees are providing qualified and independent expert services in approximately 60 countries across five continents. DEKRA holds a Platinum rating from EcoVadis, placing it among the top 1% of the world’s most sustainable companies.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/dekra-korea-to-acquire-global-product-service-strengthening-consumer-electronics-testing-and-certification-capabilities-in-korea-302746801.html

SOURCE DEKRA Asia Pacific

Continue Reading

Trending